Year: 2016

GSK Settles FCPA Charges with SEC

The SEC filed another settled FCPA action stemming from what the Order called “pervasive” practices in the China subsidiary of a multinational firm. This time GlaxoSmithKline plc was charged with internal control violations arising from the conduct of its China

Tagged with: , ,

This Week In Securities Litigation (Week ending Sept. 30, 2016)

As the government fiscal year draws to an end, the Commission filed a series of enforcement actions. Those included two insider trading cases, an action alleging violations of the whistleblower provisions, another against a community bank tied to allegations about

Tagged with: , , , ,